Literature DB >> 20298457

Stress response of prolactin-releasing peptide knockout mice as to glucocorticoid secretion.

A Mochiduki1, T Takeda, S Kaga, K Inoue.   

Abstract

Prolactin-releasing peptide (PrRP) is known to have functions in prolactin secretion, stress responses, cardiovascular regulation and food intake suppression. In addition, PrRP-knockout (KO) male mice show obesity from the age of 22 weeks and increase their food intake. The plasma concentrations of insulin, leptin, cholesterol and triglyceride are also increased in obese PrRP-KO mice. Fatty liver, hypertrophied white adipose tissue, decreased uncoupling protein 1 mRNA expression in brown adipose tissue and glucose intolerance were observed in obese PrRP-KO mice. As we reported previously, PrRP stimulates corticotrophin-releasing factor and regulates the hypothalamic-pituitary-adrenal axis. Therefore, it is speculated that PrRP regulates both food intake and metabolism as a stress responses. In the present study, we compared blood glucose and plasma glucocorticoid concentrations in PrRP-KO mice, and found that PrRP-KO mice showed higher concentrations of blood glucose and corticosterone compared to wild-type mice after restraint stress. By contrast, there were no difference in c-Fos expression in the paraventricular hypothalamic nucleus and plasma adrenocorticotrophic hormone concentrations between the two groups. These results suggest that the different stress responses as to glucocorticoid secretion may be induced by different responses of the adrenal glands between wild-type and PrRP-KO mice. Thus, we conclude that PrRP-KO mice become obese as a result of increased food intake, a change in metabolism, and abnormal stress responses as to glucose concentration and glucocorticoid secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298457     DOI: 10.1111/j.1365-2826.2010.01993.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Differential activation of chemically identified neurons in the caudal nucleus of the solitary tract in non-entrained rats after intake of satiating vs. non-satiating meals.

Authors:  Alison D Kreisler; Elizabeth A Davis; Linda Rinaman
Journal:  Physiol Behav       Date:  2014-02-06

Review 2.  Functions of two distinct "prolactin-releasing peptides" evolved from a common ancestral gene.

Authors:  Tetsuya Tachibana; Tatsuya Sakamoto
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-10       Impact factor: 5.555

3.  Reproductive Regulation of PrRPs in Teleost: The Link Between Feeding and Reproduction.

Authors:  Chuanhui Xia; Xiangfeng Qin; Lingling Zhou; Xuetao Shi; Tianyi Cai; Yunyi Xie; Wei Li; Ruixin Du; Yu OuYang; Zhan Yin; Guangfu Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-03       Impact factor: 5.555

4.  Satiation and stress-induced hypophagia: examining the role of hindbrain neurons expressing prolactin-releasing Peptide or glucagon-like Peptide 1.

Authors:  James W Maniscalco; Alison D Kreisler; Linda Rinaman
Journal:  Front Neurosci       Date:  2013-01-21       Impact factor: 4.677

Review 5.  Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Authors:  Veronika Pražienková; Andrea Popelová; Jaroslav Kuneš; Lenka Maletínská
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

6.  Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.

Authors:  Flora Alexopoulou; Esben Matzen Bech; Søren Ljungberg Pedersen; Ditte Dencker Thorbek; Ulrike Leurs; Lise Christine Biehl Rudkjær; Keld Fosgerau; Henrik H Hansen; Niels Vrang; Jacob Jelsing; Lisbeth Elster
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.996

Review 7.  The role of nucleus of the solitary tract glucagon-like peptide-1 and prolactin-releasing peptide neurons in stress: anatomy, physiology and cellular interactions.

Authors:  Marie K Holt; Linda Rinaman
Journal:  Br J Pharmacol       Date:  2021-06-26       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.